We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
231 hedge funds and large institutions have $640M invested in Sorrento Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 72 increasing their positions, 67 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
93% more call options, than puts
Call options by funds: $75.7M | Put options by funds: $39.3M
45% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 31
18% more capital invested
Capital invested by funds: $540M → $640M (+$99.7M)
5% more funds holding
Funds holding: 219 → 231 (+12)
7% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 67
Holders
231
Holders Change
+12
Holders Change %
+5.48%
% of All Funds
4.06%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
45
Increased
72
Reduced
67
Closed
31
Calls
$75.7M
Puts
$39.3M
Net Calls
+$36.5M
Net Calls Change
-$5.93M
Top Buyers
| 1 |
BlackRock
New York
|
+$18.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.1M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$11.2M |
| 4 |
JP Morgan Chase
New York
|
+$10.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.51M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$30.5M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$18.5M |
| 3 |
Goldman Sachs
New York
|
-$13.2M |
| 4 |
Morgan Stanley
New York
|
-$12.1M |
| 5 |
Jane Street
New York
|
-$9.23M |
